Trade Endava PLC - DAVA CFD
What is Endava PLC (DAVA)?
Endava PLC is a technology company specializing in digital transformation, agile software development, and automation solutions. The company provides services that include consulting, software engineering, and IT infrastructure management, catering primarily to clients in sectors such as financial services, insurance, telecommunications, and retail. Endava operates through a global delivery model, leveraging a network of delivery centers across Europe, the Americas, and other regions. Its approach emphasizes collaboration with clients to enhance business agility and operational efficiency through technology. The company focuses on emerging technologies including cloud computing, artificial intelligence, and data analytics to support its service offerings. Established with a foundation in software development, Endava has expanded its capabilities to address the evolving needs of enterprises undergoing digital transformation. The company maintains a commitment to fostering innovation and delivering scalable technology solutions that align with client business objectives. Its organizational structure supports cross-functional teams that integrate technical expertise with industry knowledge.
Endava PLC Stock Price Today: Live Overview
The price today is shaped by ongoing trade activity in JPMorgan Active Value ETF, with a current price of $4.41. The price has moved between $4.23 and $4.46 today, reflecting a daily change of -0.907%.
FAQ: Endava PLC (DAVA)
What is the current price of DAVA stock?
The stock is currently priced at $4.41.
Does DAVA pay dividends?
Endava PLC does not pay dividends.
Does DAVA have a formal corporate presence or regional headquarters in the UAE?
Endava PLC has an official regional office located in Dubai Internet City, UAE.
What is DAVA best known for?
The company is most famous for providing IT services and digital transformation solutions.
What assets are typically shown together with DAVA?
Commonly shown alongside DAVA: NVE Corp, Lisata Therapeutics, Inc, Saipem SpA
Latest shares articles



